CONTROL DE LA ASCOSFEROSIS (Ascosphaera apis) MEDIANTE EL USO DE FONDOS HIGIÉNICOS DE REJILLA by Padilla F., Flores, J. M., Campano, F.

Get full text

Effects of frequency-dependent attenuation and velocity dispersion on in vitro ultrasound velocity measurements in intact human femur specimens. by Haïat, G, Padilla, F, Cleveland, R, Laugier, P

Modelling nonlinear ultrasound propagation in bone by Cleveland, R, Johnson, P, Muller, M, Talmant, M, Padilla, F, Laugier, P

Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study by Almagro P, Lapuente A, Pareja J, Yun S, Garcia ME, Padilla F, Heredia JL, De la Sierra A, Soriano JB

Get full text

Crisis due to war: anxiety, depression and stress in the population of 13 Latin American countries by Christian R. Mejia, Aldo Alvarez-Risco, Scherlli Chamorro-Espinoza, Scherlli Chamorro-Espinoza, Jorge Andrés Castillón-Lozano, Jorge Andrés Castillón-Lozano, Medally C. Paucar, Valeria J. Padilla-F, Valeria J. Padilla-F, José Armada, Martin A. Vilela-Estrada, Victor Serna-Alarcón, Victor Serna-Alarcón, Shyla Del-Aguila-Arcentales, Jaime A. Yáñez

Get full text

Outpatient treatment with AZD7442 (tixagevimab/cilgavimab) prevented Covid-19 hospitalizations over 6 months and reduced symptom progression in the TACKLE randomized trial by Hobbs, FDR, Montgomery, H, Padilla, F, Simón-Campos, JA, Kim, K, Arbetter, D, Padilla, KW, Reddy, VP, Seegobin, S, Streicher, K, Templeton, A, Viani, RM, Johnsson, E, Koh, GCKW, Esser, MT

Analysis of SARS-CoV-2 Emergent variants following AZD7442 (tixagevimab/cilgavimab) for early outpatient treatment of COVID-19 (TACKLE trial) by Kijak, GH, Ahani, B, Arbetter, D, Chuecos, F, Gopalakrishnan, V, Beloor, J, Brady, T, Nguyen, A, Roe, TL, Schuko, N, Zhang, T, Hobbs, FDR, Padilla, F, Kelly, EJ, Montgomery, H, Streicher, K

Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-cont... by Montgomery, H, Hobbs, FDR, Padilla, F, Arbetter, D, Templeton, A, Seegobin, S, Kim, K, Campos, JAS, Arends, RH, Brodek, BH, Brooks, D, Garbes, P, Jimenez, J, Koh, GCKW, Padilla, KW, Streicher, K, Viani, RM, Alagappan, V, Pangalos, MN, Esser, MT, TACKLE Study Group